{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:03:39Z","timestamp":1790665419300,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.canrad.2022.08.008","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T02:44:45Z","timestamp":1675824285000},"page":"145-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of lymphoid volume irradiation on radiation-induced lymphopenia in head and neck cancers"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-000X","authenticated-orcid":false,"given":"M.","family":"C\u00e9saire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rambeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cherifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"G\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2022.08.008_bib0215","doi-asserted-by":"crossref","first-page":"v184","DOI":"10.1093\/annonc\/mdq185","article-title":"Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Gr\u00e9goire","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0225","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/hed.24687","article-title":"Distant metastases in head and neck cancer","volume":"39","author":"Duprez","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2022.08.008_bib0230","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.08.008_bib0235","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00262-014-1650-8","article-title":"Immune checkpoint combinations from mouse to man","volume":"64","author":"Ai","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.canrad.2022.08.008_bib0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40425-018-0395-x","article-title":"Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas","volume":"6","author":"Ho","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canrad.2022.08.008_bib0245","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/hed.23535","article-title":"Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer","volume":"36","author":"Campian","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2022.08.008_bib0250","first-page":"E1061","article-title":"Minimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer","volume":"38 Suppl. 1","author":"Cho","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2022.08.008_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2018.08.008","article-title":"Postoperative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers","volume":"86","author":"Lin","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0260","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/jcm7120512","article-title":"The prognostic significance of neutrophil-to-lymphocyte ratio in head and neck cancer patients treated with radiotherapy","volume":"7","author":"Cho","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.canrad.2022.08.008_bib0265","first-page":"813","article-title":"[Mechanisms of radiation-induced lymphopenia and therapeutic impact]","volume":"107","author":"C\u00e9saire","year":"2020","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.canrad.2022.08.008_bib0270","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/07357907.2013.767342","article-title":"Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer","volume":"31","author":"Campian","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.canrad.2022.08.008_bib0275","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ijrobp.2019.07.013","article-title":"Lymphocyte count kinetics, factors associated with the end-of-radiation-therapy lymphocyte count, and risk of infection in patients with solid malignant tumors treated with curative-intent radiation therapy","volume":"105","author":"Terrones-Campos","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.08.008_bib0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0167-8140(98)00130-3","article-title":"Impact of localized radiotherapy on blood immune cells counts and function in humans","volume":"50","author":"Belka","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0285","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.adro.2019.01.005","article-title":"Radiation-related lymphopenia after pelvic nodal irradiation for prostate cancer","volume":"4","author":"Schad","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0290","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1567-5769(03)00013-4","article-title":"Long-term immune dysfunction after radiotherapy to the head and neck area","volume":"3","author":"Verastegui","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0295","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/07357907.2012.762780","article-title":"The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.canrad.2022.08.008_bib0300","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.adro.2018.08.014","article-title":"Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors","volume":"3","author":"Ellsworth","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0305","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood.V24.3.241.241","article-title":"Studies on lymphocytes. III. Effects of extracorporeal irradiation of the circulating blood upon the lymphoreticular organs in the calf","volume":"24","author":"Cottier","year":"1964","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2022.08.008_bib0310","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.08.008_bib0315","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijrobp.2018.01.069","article-title":"Effect of radiation treatment volume reduction on lymphopenia in patients receiving chemoradiotherapy for glioblastoma","volume":"101","author":"Rudra","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.08.008_bib0320","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1073\/pnas.0709713105","article-title":"Sparse production but preferential incorporation of recently produced naive T cells in the human peripheral pool","volume":"105","author":"Vrisekoop","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.canrad.2022.08.008_bib0325","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2013-03-488411","article-title":"Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans","volume":"122","author":"Westera","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2022.08.008_bib0330","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.seminoncol.2019.07.002","article-title":"Modern radiotherapy for head and neck cancer","volume":"46","author":"Alterio","year":"2019","journal-title":"Semin Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0335","first-page":"6545","article-title":"Impact of early supportive care assessment on treatment decision in head and neck cancer before concomitant chemoradiotherapy","volume":"30","author":"Cherifi","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.canrad.2022.08.008_bib0340","doi-asserted-by":"crossref","first-page":"114268","DOI":"10.18632\/oncotarget.23217","article-title":"Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors","volume":"8","author":"Diehl","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canrad.2022.08.008_bib0345","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors","volume":"103","author":"Pike","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.08.008_bib0350","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2022.01.003","article-title":"The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: a systematic review and meta-analysis","volume":"168","author":"Dai","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.12.023","article-title":"Lymphopenia during radiotherapy in patients with oropharyngeal cancer","volume":"145","author":"Ng","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0360","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2022.08.008_bib0365","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1002\/cncr.28938","article-title":"Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life","volume":"120","author":"Spencer","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2022.08.008_bib0370","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.radonc.2016.08.009","article-title":"Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control","volume":"122","author":"Nevens","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0375","doi-asserted-by":"crossref","first-page":"103753","DOI":"10.1016\/j.cellimm.2018.01.013","article-title":"Role of tumor-infiltrating lymphocytes in patients with solid tumors: can a drop dig a stone?","volume":"343","author":"Badalamenti","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0380","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2018.00256","article-title":"Cellular composition and contribution of tertiary lymphoid structures to tumor immune infiltration and modulation by radiation therapy","volume":"8","author":"Boivin","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0385","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0360-3016(99)00550-7","article-title":"Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer","volume":"46","author":"Dawson","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.08.008_bib0390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.adro.2018.09.004","article-title":"A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer","volume":"4","author":"Routman","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0395","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14338\/IJPT-17-00033.1","article-title":"Lymphocyte-sparing effect of proton therapy in patients with esophageal cancer treated with definitive chemoradiation","volume":"4","author":"Fang","year":"2018","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.canrad.2022.08.008_bib0400","first-page":"28","article-title":"Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer","volume":"7","author":"Jensen","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0405","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0192-0561(97)00063-5","article-title":"The immunopharmacology of head and neck cancer: an update","volume":"19","author":"Hadden","year":"1997","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0410","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canrad.2022.08.008_bib0415","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/s0004-2803.2017v54n1-16","article-title":"Is total lymphocyte count related to nutritional markers in hospitalized older adults?","volume":"54","author":"Leandro-Merhi","year":"2017","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.canrad.2022.08.008_bib0420","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/cancers11091324","article-title":"Radiotherapy-induced changes in the systemic immune and inflammation parameters of head and neck cancer patients","volume":"11","author":"Bal\u00e1zs","year":"2019","journal-title":"Cancers"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:35:18Z","timestamp":1761136518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321823000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1278321823000069"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2022.08.008","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of lymphoid volume irradiation on radiation-induced lymphopenia in head and neck cancers","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2022.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}